Bad Influence? U.K. Questions Pharma’s Sway On Health Care System
This article was originally published in The Tan Sheet
Executive Summary
The U.K. House of Commons Health Committee will hold an "evidence session" Oct. 14 as part of an ongoing inquiry into the pharmaceutical industry's influence on the overall British healthcare system